Change in patient-centered outcomes of psychological well-being, sleep, and suicidality following treatment with intravenous ketamine for late-life treatment-resistant depression.

Benjamin VanderscheldenMarie Anne GebaraHanadi Ajam OughliMeryl A ButtersPatrick J BrownNuri B FarberAlastair J FlintJordan F KarpHelen LavretskyBenoit H MulsantCharles F ReynoldsSteven P RooseEric J Lenze

Published in: International journal of geriatric psychiatry (2023)

ClinicalTrials.gov identifier: NCT04504175.

Keyphrases

sleep quality
depressive symptoms
physical activity
high dose
low dose
combination therapy